Tuberculosis Diagnostics Market 2021-2026: Size, Share, Growth, Outlook and Forecast

According to the latest report by IMARC Group, titled “Tuberculosis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global tuberculosis diagnostics market is expected to exhibit moderate growth during 2021-2026. Looking forward, IMARC Group expects the global tuberculosis diagnostics market to grow at a CAGR of around 5% during 2021-2026. Tuberculosis (TB) refers to a contagious bacterial disease that primarily affects the lungs (pulmonary) and can also spread to the brain or spine (extrapulmonary). This disease is diagnosed by either the TB blood test or the Mantoux tuberculin skin test (TST). Depending on the infected organs, additional tests may be required to confirm the disease. For pulmonary TB, microscopic examination of the patient’s sputum and acid-fast staining is performed, along with chest radiography to detect any chest abnormalities. For extrapulmonary TB, endoscopy, CT, ultrasound scan, MRI, lumbar punctures, etc., can be performed.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Sample Report: https://www.imarcgroup.com/tuberculosis-diagnostics-market/requestsample

Market Trends:

The rising prevalence of multi-drug resistant (MDR) tuberculosis is primarily driving the tuberculosis diagnostics market. The emergence of advanced technologies, such as the Point-of-Care (POC) diagnostic method, Interferon-Gamma Release Assay (IGRA), Nucleic acid amplification tests (NAATs), etc., for providing more accurate and prompt results is further augmenting the market growth. Additionally, continuous improvements in healthcare infrastructures and rising consumer awareness towards various diagnostic procedures are expected to further bolster the global market for tuberculosis diagnostics in the coming years.

Explore Full Report with TOC & List of Figure: https://bit.ly/3h6tKub

Key Market Segmentation:                

Competitive Landscape:                        

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Abbott Laboratories
  • Alere Inc.
  • Becton Dickinson and Company
  • BioMérieux
  • Cepheid Inc.
  • Epistem Ltd.
  • Roche Holding AG
  • Hain Lifescience GmbH
  • Hologic Inc.
  • QIAGEN GmbH
  • Siemens
  • Thermo Fisher Scientific Inc.

Breakup by Disease Stage:

  • Latent TB
  • Active TB

Breakup by Test Type:

  • Radiographic Test
  • Laboratory Test
    • Smear Microscopy
    • Culture-based Test
  • Nucleic Acid Testing
  • Cytokine Detection Test
  • Drug Resistance Test
  • Others

Breakup by End-User:

  • Hospitals and Clinics
  • Diagnostics and Research Laboratories
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the Report:

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • COVID-19 Impact on the Market
  • Porter’s Five Forces Analysis
  • Historical, Current and Future Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Structure of the Market
  • Value Chain Analysis
  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Reply

Your email address will not be published. Required fields are marked *